explore -WSS

explore

author：fashion 2025-10-01 20:16:40 - browse：516

An orange Flovent inhaler on a white background. -- health coverage from STAT — Adobe

As of Jan. 1, thousands of asthma patients in the U.S. will no longer be able to get refills for Flovent — one of the most popular inhalers in the U.S. for nearly 30 years.

Flovent’s manufacturer, GSK, has discontinued both versions of the product — Flovent HFA, an inhalation aerosol, and Flovent Diskus, an inhalation powder — and replaced each with what is known as an “authorized generic,” essentially the same product sold under a private label. Prasco, a U.S. drugmaker specializing in authorized generics, will distribute the new inhaler, sold as fluticasone.

The timing of the change is telling: Flovent’s price rose nearly 50% since 2014, according to GoodRx, leaving the drug vulnerable to the new Medicaid penalties going into effect as of this year for medications with price increases that outpace inflation. By discontinuing the brand-name inhaler but continuing to earn money from the authorized generic, GSK will be able to avoid paying a penalty.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Dobbs anniversary: the lost opportunity of abortion as health care

leisure time

explore

WSS

The cancer drug shortage isn’t new — and neither are the solutions

Supreme Court strikes down use of affirmative action

Cherokee Nation medical school graduates its first class

United colonoscopy coverage change 'may cost lives,' doctors say

The high cost of giving birth even with insurance

ChatGPT in medicine: STAT answers readers' burning questions

focus

explore

explore

After affirmative action ruling, medical educators look to 'holistic review'

Fertility clinic egg and embryo storage is a disaster

United colonoscopy coverage change 'may cost lives,' doctors say

Medicare details structure of new drug price negotiation program

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Abbott's new stent may help patients with peripheral artery disease

George Santos makes 1st court appearance after pleading not guilty to 13 counts

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Cancer drug shortages should be causing more outrage

WuXi Biologics execs register to lobby as Congress comes for the company

focus

Cherokee Nation medical school graduates its first class

Medicare details structure of new drug price negotiation program

23andMe had bad news about my health. I wish a person had delivered it

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

Malaria cases in Florida and Texas: Here’s what you need to know

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Wikipedia

leisure time

explore

entertainment